These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15679754)

  • 1. Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approach.
    Medioni J; Berlin I; Mallet A
    Addiction; 2005 Feb; 100(2):247-54. PubMed ID: 15679754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine replacement therapy for long-term smoking cessation: a meta-analysis.
    Etter JF; Stapleton JA
    Tob Control; 2006 Aug; 15(4):280-5. PubMed ID: 16885576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.
    Covey LS; Glassman AH; Jiang H; Fried J; Masmela J; LoDuca C; Petkova E; Rodriguez K
    Addiction; 2007 Aug; 102(8):1292-302. PubMed ID: 17624979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nicotine replacement therapy during pregnancy and stillbirth: a cohort study.
    Strandberg-Larsen K; Tinggaard M; Nybo Andersen AM; Olsen J; Grønbaek M
    BJOG; 2008 Oct; 115(11):1405-10. PubMed ID: 18717669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precessation treatment with nicotine skin patch facilitates smoking cessation.
    Rose JE; Behm FM; Westman EC; Kukovich P
    Nicotine Tob Res; 2006 Feb; 8(1):89-101. PubMed ID: 16497603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers.
    Sun HQ; Guo S; Chen DF; Jiang ZN; Liu Y; Di XL; Yang FD; Zhang XY; Kosten TR; Lu L
    Am J Drug Alcohol Abuse; 2009; 35(3):183-8. PubMed ID: 19462302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case studies of three pregnant smokers and their use of nicotine replacement therapy.
    Hotham ED; Gilbert AL; Atkinson ER
    Midwifery; 2005 Sep; 21(3):224-32. PubMed ID: 15967546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of selectors of nicotine replacement therapy.
    Shiffman S; Di Marino ME; Sweeney CT
    Tob Control; 2005 Oct; 14(5):346-55. PubMed ID: 16183986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of nicotine replacement therapy among smoking-cessation attempters.
    Burns EK; Levinson AH
    Am J Prev Med; 2008 Mar; 34(3):212-5. PubMed ID: 18312809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment with varenicline and nicotine replacement therapy.
    Ebbert JO; Burke MV; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 May; 11(5):572-6. PubMed ID: 19351781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy.
    Rukstalis M; Jepson C; Patterson F; Lerman C
    J Subst Abuse Treat; 2005 Jun; 28(4):297-304. PubMed ID: 15925263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women.
    Cepeda-Benito A; Reynoso JT; Erath S
    J Consult Clin Psychol; 2004 Aug; 72(4):712-22. PubMed ID: 15301656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
    Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
    Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical and pharmacological direct costs of a 9-week smoking cessation programme.
    Wasserfallen JB; Digon P; Cornuz J
    Eur J Prev Cardiol; 2012 Jun; 19(3):565-70. PubMed ID: 21450562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing trends for nicotine replacement therapy in primary care.
    Tilson L; Bennett K; Barry M
    Ir Med J; 2004 Oct; 97(9):270-3. PubMed ID: 15568584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the mu-opioid receptor gene with smoking cessation.
    Munafò MR; Elliot KM; Murphy MF; Walton RT; Johnstone EC
    Pharmacogenomics J; 2007 Oct; 7(5):353-61. PubMed ID: 17224915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.